首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   919908篇
  免费   64612篇
  国内免费   2386篇
耳鼻咽喉   12959篇
儿科学   29575篇
妇产科学   26480篇
基础医学   128964篇
口腔科学   25152篇
临床医学   76154篇
内科学   188661篇
皮肤病学   19880篇
神经病学   72885篇
特种医学   36977篇
外国民族医学   336篇
外科学   145207篇
综合类   19116篇
一般理论   252篇
预防医学   66399篇
眼科学   20725篇
药学   65106篇
中国医学   1862篇
肿瘤学   50216篇
  2018年   9958篇
  2017年   7684篇
  2016年   8123篇
  2015年   9201篇
  2014年   12879篇
  2013年   20013篇
  2012年   27146篇
  2011年   28887篇
  2010年   17447篇
  2009年   16430篇
  2008年   27466篇
  2007年   29190篇
  2006年   29213篇
  2005年   28786篇
  2004年   27488篇
  2003年   26625篇
  2002年   26203篇
  2001年   42095篇
  2000年   43421篇
  1999年   36907篇
  1998年   10067篇
  1997年   9217篇
  1996年   9153篇
  1995年   8489篇
  1994年   8114篇
  1993年   7621篇
  1992年   28414篇
  1991年   27146篇
  1990年   26545篇
  1989年   25443篇
  1988年   23660篇
  1987年   23277篇
  1986年   22327篇
  1985年   21229篇
  1984年   15864篇
  1983年   13521篇
  1982年   8102篇
  1979年   14625篇
  1978年   10224篇
  1977年   8641篇
  1976年   8171篇
  1975年   8972篇
  1974年   10719篇
  1973年   10206篇
  1972年   9679篇
  1971年   8937篇
  1970年   8598篇
  1969年   8042篇
  1968年   7706篇
  1967年   7097篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
85.
86.
87.
Fibroepithelial polyps (FEPs) are common, benign intraoral lesions that tend to develop slowly at predictable sites, often in response to local irritation or trauma. Historical precedent often results in referral to oral and maxillofacial surgery (OMFS) departments for biopsy, often irrespective of symptoms, and histological assessment. OMFS and pathology services are struggling to cope with an increasing workload that will potentially lead to widespread delays to diagnosis and treatment. Over the past 20 years, clinical pathways and guidance have been developed to ensure that healthcare interventions, such as the removal of third molars, tonsils, skin tags, and benign moles, are evidence-based, have a net patient benefit, and ensure the best use of finite NHS resources. However, no such guidance exists for intraoral lesions and we regard this as an oversight. We analysed the removal of 682 FEPs over a seven-year period and report sensitivities of 92.4% for a “confirmed clinical suspicion of an FEP” and 99.7% for a “confirmed clinical suspicion of a benign diagnosis”. The incidence of non-benign disease was 0.3%. Primary care dentists should be able to diagnose and monitor FEPs and refer only if symptoms are serious or in high-risk patients or sites. Adopting this practice across the UK could free up to 1825 four-hour OMFS clinics, 405 hours of consultant histopathologists’ time, and recurring savings to the NHS estimated to be in the region of £620 000/annum. We believe that the removal of FEPs should be reclassified as an “intervention not normally funded”, and the time and resources put to better use treating patients with lesions of questionable pathology.  相似文献   
88.
Journal of Behavioral Medicine - Understanding associations between mothers’ and children’s physical activity and sedentary behavior on more fine-grained timescales can provide insights...  相似文献   
89.
90.
In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Access to these technologies in the UK is very variable. Some technologies are recommended by the National Institute for Health and Care Excellence, while others have not been appraised, and new technologies are emerging all the time. Additionally, different guidelines for adults and children further complicate access to diabetes technology in the transition from paediatric to adult care. Against this background, Diabetes UK and NHS England have brought together a multidisciplinary group of experts, including clinicians and people with diabetes, to develop this consensus guideline, combining the different technologies into a common pathway to aid clinical and policy decision‐making. We created a pathway that supports the incremental addition of technology as monotherapy and then dual therapy in the same way that we incrementally add in therapeutic agents to support people with Type 2 diabetes to achieve their personalized glycaemic targets. The pathway emphasizes the importance of structured education, specialist support and appropriate access to psychological therapies, as essential pillars for optimized use of diabetes‐related technology, and recommends the re‐evaluation of its use when the individual is unable either to use the technology appropriately or to achieve the intended outcomes. This pathway is endorsed by UK‐wide clinical and patient associations and we recommend that providers and commissioners use it to ensure the right individual with diabetes has access to the right technology in a timely way to help achieve better outcomes.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号